Development of New Catalytic and Enantioselective Reactions

描述（由申请人提供）：手性有机分子的高产和选择性制备对治疗剂的可用性至关重要。发展催化、对映选择性合成方法是化学和医学领域一个迫切的目标。在有机合成中最有用的组成部分是光学纯胺和醇；我们的计划将解决这些重要分子的对映选择性制备问题。我们将建立新的、实用的、高效的和高度对映选择性的方法来合成仲胺和叔胺和醇，否则难以获得高收率和光学纯度。我们项目的一个主要目标是开发新的手性配体和催化剂，所有这些都是基于氨基酸的。氨基酸基分子的一个关键优势是它们可以很容易地制备和修饰，允许快速（机制驱动的）合成和筛选变体，以便最适合特定转化的催化剂可以迅速确定。我们将开发新的基于氨基酸的手性配体和实用的方法，以有效的对映选择性添加烯醇烷和硝基烷烃到醛胺（曼尼希反应）。催化剂的发现将以机械原理为指导，并将通过本项目制定的筛选方案来完成。新的合成方法将为合成各种非环胺和环胺提供实用的（不需要蒸馏溶剂，不需要空气排除）和独特的程序，这些方法不能通过其他催化对映选择性方法制备。我们还将开发新的以氨基酸为基础的手性配体和对映选择性添加碳亲核试剂到酮亚胺的方法。上述原理将用于催化不对称烷基化和曼尼希反应的发展，这些反应提供了获得光学富集的α -和β -季氨基酸的途径。我们还将开发新的手性氨基酸配体、催化剂和方法，用于有效的对映选择性合成醇。以氨基酸为基础的手性配体将被开发出来，以影响ag催化的一系列烯醇硅烷到各种酮的不对称醛醇加成。最后，将开发一类新的低分子量、易得的氨基酸基手性催化剂，用于醇的对映选择性硅基化反应。在所有的研究中，将证明在制备高光学纯度的生物活性化合物方面的效用。

DESCRIPTION (provided by applicant): High yielding and selective preparation of chiral organic molecules is critical to the availability of therapeutic agents. Development of catalytic, enantioselective synthetic methods is a compelling objective in chemistry and medicine. Among the most useful building blocks in organic synthesis are optically pure amines and alcohols; our program will address issues regarding enantioselective preparation of these important classes of molecules. We will establish new, practical, and efficient and highly enantioselective methods for the synthesis of secondary and tertiary amines and alcohols that are otherwise difficult to obtain in high yield and optical purity. One main goal of our program is the development of new chiral ligands and catalysts, all of which are amino acid-based. A crucial advantage of amino acid-based molecules is that they can be easily prepared and modified, allowing for rapid (mechanism-driven) synthesis and screening of variants so that catalysts that best fit a specific set of transformations can be identified expeditiously. We will develop new amino acid-based chiral ligands and practical methods for efficient enantioselective additions of enolsilanes and nitroalkanes to aldimines (Mannich reactions). Catalyst discovery will be guided by mechanistic principles and will be accomplished by screening protocols developed in this program. The new synthetic methods will offer practical (distilled solvents, air exclusion not required) and unique procedures for the synthesis of various acyclic and cyclic amines that cannot be prepared by alternative catalytic enantioselective methods. We will also develop new amino acid-based chiral ligands and methods for efficient enantioselective additions of carbon nucleophiles to ketoimines. The aforementioned principles will be used in the development of catalytic asymmetric alkylations and Mannich reactions that provide access to optically enriched alpha- and beta-quaternary amino acids. We will also develop new chiral amino acid-based ligands, catalysts and methods for efficient enantioselective synthesis of alcohols. Amino acid-based chiral ligands will be developed that effect Ag-catalyzed asymmetric aldol additions for a range of enolsilanes to various ketones. Finally, a new class of low molecular weight and easily available amino acid-based chiral catalysts will be developed for enantioselective silylations of alcohols. In all studies utility in the preparation of biologically active compounds in high optical purity will be demonstrated.